PHarmaceutical tech@2x
  • News

    Most Read

    • Fire at Serum Institute of India facility kills five people
    • Akron Biotech, Octapharma enter Human AB Serum global production deal
    • Cross-EU drug supply chain to be most affected post Brexit: Poll

    Most Recent

    Manufacturing

    Fire at Serum Institute of India facility kills five people

    21 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • PTF: Spotting new Covid-19 variants with genome mapping
    • Tackling Covid-19 variants with next-generation vaccines
    • Pandemic has been catastrophic for women in Canada – leading macroeconomic influencers

    Most Recent

    Drug Development

    PTF: Spotting new Covid-19 variants with genome mapping

    21 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • Pharma jobs weekly snapshot: Chase Sun Pharma leads the way, and plasma companies engage in collection-focused hiring
    • PTF: Spotting new Covid-19 variants with genome mapping
    • Fire at Serum Institute of India facility kills five people

    Most Recent

    Pharma jobs weekly snapshot: Chase Sun Pharma leads the way, and plasma companies engage in collection-focused hiring

    21 Jan 2021
  • Themes
  • Deals

    Most Read

    • Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership
    • Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m
    • NewAmsterdam Pharma raises $196m through Series A funding round

    Most Recent

    Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership

    19 Jan 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • TOTE® SYSTEMS
    • RSD
    • Kiskun Meridian

    Most Recent

    Manufacturing

    TOTE® SYSTEMS

    20 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Metabolic disorders on Twitter: Diabetes leads mentions in August 2019

Metabolic disorders on Twitter: Diabetes leads mentions in August 2019

Pharmaceutical Technology lists the top tweeted terms on metabolic disorders in August 2019, based in...

19 September 2019

Latest News

Regulation

UAE approves Sputnik V Covid-19 vaccine for emergency use

22 Jan 2021
Manufacturing

Fire at Serum Institute of India facility kills five people

21 Jan 2021
Drug Development

Akron Biotech, Octapharma enter Human AB Serum global production deal

21 Jan 2021
Supply Chain

Cross-EU drug supply chain to be most affected post Brexit: Poll

21 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more